AstraZeneca
Lynparza extends progression-free survival in gBRCAm metastatic pancreatic cancer
February 26, 2019Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, MSD, Pancreatic cancer, lynparza, pharma
AstraZeneca and MSD have lifted the curtain on new Phase 3 data for Lynparza (olaparib), confirming that the drug generated …
Top Ten most popular articles on Pharmafile.com this week
February 22, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, China, MedImmune, Xeljanz, asthma, diabetes, keytruda, osteoarthritis, pharma, rare disease
Happy Friday! With the weekend within reach, check out our run-down of the top ten most popular articles on Pharmafile.com …
Avara Avlon falls into administration putting 270 Bristol jobs at risk
February 21, 2019Manufacturing and Production AstraZeneca, Avara Avlon, Bristol, CDMO, Jobs, UK, manufacturing
Bristol-based pharma firm Avara Avlon Pharmaceuticals has fallen into administration putting the jobs of all 270 of its staff at …
AstraZeneca to retire MedImmune brand amid restructuring
February 15, 2019Medical Communications AstraZeneca, Business, MedImmune, R&D, biologics, restructuring
AstraZeneca is retiring the MedImmune brand as part of a restructuring that will see biologics integrated into two new R&D …
AstraZeneca scores accelerated approval in US and Europe for respiratory syncytial virus drug
February 5, 2019Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, EMA, FDA, MEDI8897, pharma, respiratory syncytial virus
It’s a double victory for AstraZeneca as the company announced its F monoclonal antibody MEDI8897 has been granted accelerated review …
Top Ten most popular articles on Pharmafile.com this week!
January 11, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bristol-Myers Squibb, Shire, Takeda, bristol myers squibb, death row, pharma, top 10
With the completion of Takeda’s £46 billion acquisition of Shire finally done, another even bigger merger was announced as US …
AstraZeneca to shut down twin Colorado manufacturing sites, impacting over 200 jobs
January 10, 2019Manufacturing and Production AstraZeneca, US, job cuts, pharma
UK-based drug firm AstraZeneca has revealed it is set to shed more than 200 positions from its operations at two …
AstraZeneca hire controversial cancer doc to head new Oncology R&D unit
January 8, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, journal, oncology
The Anglo-Swedish multinational AstraZeneca has named Dr José Baselga as the firm’s new head of research and development in oncology.The …
Ironwood Pharmaceuticals names AstraZeneca veteran Mark Mallon as new CEO
January 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, CEO, Ironwood, Sweden, mark mallon
The Cambridge, Massachusetts pharma firm Ironwood Pharmaceuticals has announced the appointment of AstraZeneca veteran Mark Mallon in preparation for the …
AstraZeneca loses two senior executives as biotechs appoint new CEOs
January 7, 2019Sales and Marketing AstraZeneca, CEO, Ironwood Pharmaceuticals, biotech, immunocore
Two of AstraZeneca’s senior executives have been poached by the biotech firms Ironwood Pharmaceuticals and Immunocore, as the two biotechnology …
NICE recommends AstraZeneca’s Fasenra as third treatment option for severe asthma
January 4, 2019Medical Communications, Sales and Marketing AstraZeneca, Fasenra, NHS, NICE, UK, asthma, pharma
It’s good news for both asthma patients and AstraZeneca after UK drug watchdog NICE saw fit to recommend the drugmaker’s …
Top Ten most popular articles on Pharmafile.com this week!
December 21, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Eli Lilly, Novartis, Teva, Tilray, brexit, celltrion, pharma, top 10
Deals dominated this week as GSK and Pfizer announced that they would combine their consumer healthcare units in a collaboration …
AstraZeneca scores hat trick in ovarian cancer and anaemia clinical trials
December 20, 2018Research and Development AstraZeneca, anaemia, oncology, ovarian cancer, pharma
Anglo-Swedish multinational AstraZeneca has revealed that its ovarian cancer drug (Lynparza) and anaemia treatment (Roxadustat) have met their goals in …
China becomes first country to approve roxadustat in chronic kidney disease
December 19, 2018Research and Development, Sales and Marketing AstraZeneca, China, chronic kidney disease, pharma
AstraZeneca has announced that its partner Fibrogen has secured the first national approval for its hypoxia-inducible factor prolyl hydroxylase inhibitor …
AstraZeneca partners up with CRUK for new UK cancer drug discovery facility
December 10, 2018Research and Development, Sales and Marketing AstraZeneca, CRUK, Cancer, pharma
AstraZeneca is to team up with Cancer Research UK to build a new centre of excellence for accelerating the discovery …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
